Health A-Z

Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder characterized by muscle weakness and fatigue, particularly in the limbs. It is caused by antibodies that target voltage-gated calcium channels at the neuromuscular junction, leading to impaired release of acetylcholine and muscle weakness. Here's an overview of its symptoms, treatment options, and diagnosis.

1. Muscle Weakness: Weakness typically begins in the proximal muscles (e.g., thighs, hips, shoulders) and may progress to involve the distal muscles (e.g., hands, feet). Muscle weakness often improves with repeated use (i.e., "warm-up" phenomenon).

2. Fatigue: Fatigue is a common symptom of LEMS, often exacerbated by physical activity or prolonged muscle use.

3. Autonomic Symptoms: Some individuals with LEMS may experience autonomic symptoms, such as dry mouth, constipation, erectile dysfunction, or orthostatic hypotension (low blood pressure upon standing).

4. Reflexes: Reflexes may be reduced or absent, particularly in the lower extremities.

1. Immunosuppressive Therapy: Immunosuppressive medications, such as corticosteroids, azathioprine, mycophenolate mofetil, or rituximab, may be prescribed to suppress the immune response and reduce antibody production.

2. Symptomatic Treatment:

   • 3,4-Diaminopyridine (3,4-DAP): 3,4-DAP is a potassium channel blocker that increases the release of acetylcholine at the neuromuscular junction, improving muscle strength and reducing fatigue. It is often used as a symptomatic treatment for LEMS.
   • Acetylcholinesterase Inhibitors: Medications such as pyridostigmine may be prescribed to enhance acetylcholine activity at the neuromuscular junction and alleviate muscle weakness.

3. Plasma Exchange (Plasmapheresis): Plasma exchange may be performed to remove circulating antibodies from the blood and temporarily improve symptoms in individuals with severe LEMS exacerbations.

4. Intravenous Immunoglobulin (IVIG): IVIG may be administered to modulate the immune response and reduce antibody levels in individuals with LEMS who do not respond to other treatments.

1. Electrodiagnostic Studies: Electromyography (EMG) and nerve conduction studies (NCS) can help assess neuromuscular function and detect characteristic abnormalities, such as low-amplitude compound muscle action potentials (CMAPs) and incremental responses on repetitive nerve stimulation.

2. Autoantibody Testing: Blood tests may be performed to detect antibodies against voltage-gated calcium channels (VGCCs) or other components of the neuromuscular junction, confirming the diagnosis of LEMS.

3. Imaging Studies: Imaging studies such as chest CT scans may be performed to evaluate for underlying malignancies, particularly small cell lung cancer, which is associated with LEMS in a significant proportion of cases.